Kristen A Johnson (Kristen Johnson)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Nature communications

Science (New York, N.Y.)

California Institute for Biomedical Research

University of California San Diego (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

California Institute for Biomedical Research Apr 03 2016 - Sep 30 2018

United States

Principal Investigator :: Biology

Genomics Institute of the Novartis Research Foundation Apr 01 2007 - Mar 28 2016

United States

Senior Investigator :: Drug Disovery

Education History

University of California San Diego - Nov 21 2006

United States

PHD :: Molecular Pathology

Publications

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Emily N Chin, Chenguang Yu, Vincent F Vartabedian, Ying Jia, Manoj Kumar, Ana M Gamo, William Vernier, Sabrina H Ali, Mildred Kissai, Daniel C Lazar, Nhan Nguyen, Laura E Pereira, Brent Benish, Ashley K Woods, Sean B Joseph, Alan Chu, Kristen A Johnson, Philipp N Sander, Francisco Martínez-Peña, Eric N Hampton, Travis S Young, Dennis W Wolan, Arnab K Chatterjee, Peter G Schultz, H Michael Petrassi, John R Teijaro, Luke L Lairson
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (New York, N.Y.) 369 (6506) (2020)
Chao Li, Jie Wang, Lisa M Barton, Shan Yu, Maoqun Tian, David S Peters, Manoj Kumar, Antony W Yu, Kristen A Johnson, Arnab K Chatterjee, Ming Yan, Phil S Baran
Decarboxylative borylation. Science (New York, N.Y.) 356 (6342) (2017)

Kristen A Johnson.css-eqlu8i{font-size:small;padding-left:4px;} (Kristen Johnson)

Publication Activity (10 Years)

Top Topics

Top Venues

Kristen A Johnson (Kristen Johnson)